Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
May 31, 2026 -130.9%
February 28, 2026 -132.9%
November 30, 2025 -109.1%
August 31, 2025 0.14%
May 31, 2025 -206.1%
February 28, 2025 -103.9%
November 30, 2024 -58.07%
August 31, 2024 -72.83%
May 31, 2024 -127.3%
February 29, 2024 -188.6%
November 30, 2023 -96.17%
August 31, 2023 -66.08%
May 31, 2023 -161.7%
February 28, 2023 -148.5%
November 30, 2022 -109.7%
August 31, 2022 -126.5%
May 31, 2022 -33.17%
February 28, 2022 -1.36%
November 30, 2021 -24.22%
August 31, 2021 -122.3%
May 31, 2021 -162.3%
February 28, 2021 -58.55%
November 30, 2020 -125.2%
August 31, 2020 -165.4%
May 31, 2020 -17.86%
Date Value
February 29, 2020 -73.15%
November 30, 2019 -30.40%
August 31, 2019 -42.39%
May 31, 2019 -67.36%
February 28, 2019 -53.81%
November 30, 2018 -31.80%
August 31, 2018 -35.49%
May 31, 2018 -59.06%
February 28, 2018 -23.44%
November 30, 2017 -16.65%
August 31, 2017 -14.34%
May 31, 2017 -23.86%
February 28, 2017 -20.27%
November 30, 2016 -14.17%
August 31, 2016 -3.93%
May 31, 2016 -92.43%
February 29, 2016 -9.91%
November 30, 2015 -5.73%
August 31, 2015 -5.62%
May 31, 2015 16.26%
February 28, 2015 -9.02%
November 30, 2014 -21.00%
August 31, 2014 -21.20%
May 31, 2014 10.06%
February 28, 2014 1.78%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Univec, Inc. -1.48K%
Lantheus Holdings, Inc. 19.33%
Zomedica Corp. -39.58%
IDEXX Laboratories, Inc. 27.82%
Neogen Corp. -5.02%